Eam Investors, LLC A Tyr Pharma Inc Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.75 - $7.54 $1.2 Million - $1.9 Million	-252,280 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.29 - $9.5 $54,755 - $71,354	-7,511 Reduced 2.89%	252,280 $1.89 Million
Q3 2021 Nov 12, 2021	BUY	$4.22 - $12.48 $1.1 Million - $3.24 Million	259,791 New	259,791 $2.36 Million

37.2M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.